Organs-on-a-chip (OOCs) are microfluidic devices that replicate the structure and function of human organs in vitro on a small scale. These devices consist of microfabricated chambers, channels, and compartments that simulate the microarchitecture and physiological environment of specific organs, enabling the study of organ-level responses to drugs, toxins, and diseases in a controlled laboratory setting. Each organ-on-a-chip device is designed to mimic the key features of a particular organ or tissue, such as the lung, liver, heart, intestine, kidney, or brain. By incorporating living cells, extracellular matrix components, and fluid flow systems into the device, OOCs can reproduce the complex interactions between different cell types, the mechanical forces experienced by cells in vivo, and the dynamic transport of nutrients, oxygen, and signalling molecules within the organ. One of the key advantages of organs-on-a-chip is their ability to recapitulate the physiological and pathological responses of human organs more accurately than traditional 2D cell culture systems or animal models. OOCs provide a more relevant platform for drug screening, toxicity testing, and disease modelling, as they better mimic the cellular microenvironment, tissue architecture, and functional properties of human organs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy